Restriction of LABA use to combination ICS/LABA inhaler therapy in asthma

被引：7
|
作者：
Beasley, Richard [1 ,2 ]
Fingleton, James [1 ,2 ]
Weatherall, Mark [2 ,3 ]
机构：
[1] Med Res Inst New Zealand, Dept Internal Med, Wellington 6242, New Zealand
[2] Capital & Coast Dist Hlth Board, Dept Internal Med, Wellington, New Zealand
[3] Univ Otago Wellington, Dept Med, Wellington, New Zealand
来源：
THORAX | 2013年 / 68卷 / 02期
关键词：
RANDOMIZED CONTROLLED-TRIALS; FLUTICASONE PROPIONATE; EXTERNAL VALIDITY; SALMETEROL; CORTICOSTEROIDS; ADHERENCE; ADULTS; RISK; METAANALYSIS; MORTALITY;
D O I：
10.1136/thoraxjnl-2012-202483
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：119 / 120
页数：2
相关论文
共 50 条
  • [1] Call for withdrawal of LABA single-therapy inhaler in asthma
    Beasley, Richard
    Perrin, Kyle
    Weatherall, Mark
    Wijesinghe, Meme
    LANCET, 2010, 376 (9743) : 750 - 751
  • [2] Combination ICS/fast-onset LABA inhaler as maintenance and reliever therapy: the future for uncontrolled adult asthma?
    Patel, Mitesh
    Pilcher, Janine
    Beasley, Richard
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2013, 7 (05) : 451 - 454
  • [3] Use of ICS/LABA on Asthma Exacerbation Risk in Patients Within a Medical Group
    Stanford, Richard H.
    Nagar, Saurabh
    Lin, Xiwu
    O'Connor, Richard D.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2015, 21 (11) : 1014 - 1019
  • [4] A safety comparison of LABA plus LAMA vs LABA plus ICS combination therapy for COPD
    Matera, Maria Gabriella
    Calzetta, Luigino
    Puxeddu, Ermanno
    Rogliani, Paola
    Cazzola, Mario
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (05) : 509 - 517
  • [5] Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study
    Monteagudo, Monica
    Nunez, Alexa
    Barrecheguren, Miriam
    Miravitlles, Marc
    ARCHIVOS DE BRONCONEUMOLOGIA, 2022, 58 (10): : 699 - 707
  • [6] Does adherence to ICS/LABA therapy affect response to mepolizumab in the treatment of severe asthma?
    d'Ancona, Grainne
    Green, Linda
    Fernandes, Mariana
    Roxas, Cris
    Osman, Leyla
    Stewart-Knight, Kirsten
    Kavanagh, Joanna
    Nanzer-Kelly, Alexandra
    Jackson, David
    Kent, Brian
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [7] Adding a LAMA to ICS/LABA Therapy A Meta-analysis of Triple Combination Therapy in COPD
    Calzetta, Luigino
    Cazzola, Mario
    Matera, Maria Gabriella
    Rogliani, Paola
    CHEST, 2019, 155 (04) : 758 - 770
  • [8] Baseline Characteristics and ICS/LAMA/LABA Response in Asthma: Analyses From the CAPTAIN Study
    Boulet, Louis -Philippe
    Abbott, Carl
    Brusselle, Guy
    Edwards, Dawn
    Oppenheimer, John
    Pavord, Ian D.
    Pizzichini, Emilio
    Sagara, Hironori
    Slade, David
    Wechsler, Michael E.
    Gibson, Peter G.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (05) : 1244 - 1253.e8
  • [9] Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety Profile
    Rogliani, Paola
    Cavalli, Francesco
    Chetta, Alfredo
    Cazzola, Mario
    Calzetta, Luigino
    JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 565 - 577
  • [10] Comparative analysis of real-world data on the efficacy and safety of and adherence to ICS/LABA combinations in asthma management
    Park, Hee Sun
    Lee, Jungkuk
    Kim, Hasung
    Woo, Seong-Dae
    RESPIRATORY RESEARCH, 2025, 26 (01)
12345